QINLOCK

LIVE

Serial Number

88680336

Owner

Deciphera Pharmaceuticals, LLC

Attorney

Jessica L. Rothstein

First Use Date

May 16, 2020

Filing Date

Nov 5, 2019

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

QINLOCK Trademark

Serial Number: 88680336 • Registration: 6165745

QINLOCK is a trademark filed by Deciphera Pharmaceuticals, LLC on November 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals), Class 44 (Medical Services). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

Deciphera Pharmaceuticals, LLC (18 trademarks)

200 Smith Street
Waltham, MA 02451

Entity Type: 16

Legal Representation

Attorney of Record

Jessica L. Rothstein

3,878 trademarks filed View all →

Correspondence Address

Jessica L. Rothstein GOODWIN PROCTER LLP

620 EIGHTH AVENUE

NEW YORK, NY 10018

UNITED STATES

Trademark Details

Filing Date

November 5, 2019

Registration Date

September 29, 2020

First Use Anywhere

May 16, 2020

First Use in Commerce

May 20, 2020

Published for Opposition

May 12, 2020

Goods & Services

medical services, namely, medical treatment for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma

pharmaceutical oncology treatments, namely, preparations for gastrointestinal stromal tumors, systemic mastocytosis, glioma, non-small cell lung cancer, germ cell cancer, penile cancer, melanoma and soft tissue sarcoma

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 29, 2025 REM1

REGISTERED-PRINCIPAL REGISTER

Sep 29, 2020 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 25, 2020 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 24, 2020 CNPR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 13, 2020 EXRA

STATEMENT OF USE PROCESSING COMPLETE

Aug 12, 2020 SUPC

SOU EXTENSION 1 GRANTED

Aug 12, 2020 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 12, 2020 AITU

USE AMENDMENT FILED

Jul 27, 2020 IUAF

SOU EXTENSION 1 FILED

Jul 27, 2020 EXT1

SOU TEAS EXTENSION RECEIVED

Jul 27, 2020 EEXT

TEAS STATEMENT OF USE RECEIVED

Jul 27, 2020 EISU

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Jul 7, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 12, 2020 NPUB

PUBLISHED FOR OPPOSITION

May 12, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Apr 22, 2020 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 27, 2020 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Mar 26, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Mar 26, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Mar 26, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 13, 2020 GNRN

NON-FINAL ACTION E-MAILED

Feb 13, 2020 GNRT

NON-FINAL ACTION WRITTEN

Feb 13, 2020 CNRT

ASSIGNED TO EXAMINER

Feb 10, 2020 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 9, 2019 NWOS

NEW APPLICATION ENTERED

Nov 8, 2019 NWAP

Related Trademarks

More from this Owner

MY ROMVIMZA

DECIPHERA ACCESSPOINT

ROMVIMZA

More in Same Class

ARVIAT PHARMACEUTICALS

KRYPTEK

Serial #79278924

WITH ICAP TECHNOLOGY

WMBIO

C60 BUCKYOL